Recently, peroxisome proliferator-activated receptor gamma (PPARγ) agonist drugs such as rosiglitazone sensitize PTEN-deficient resistant human lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy [99]. Here, PPARG is linked to lung cancer.